Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Hiserodt

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Cancer Investigation|January 1, 1993
Lymphokine-activated killer cells: biology and relevance to diseaseJ C Hiserodt
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|December 1, 1991
Some thoughts on the cytolytic mechanism of natural killer lymphocytesJ C Hiserodt
Advances in Experimental Medicine and Biology|January 1, 1985
A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the lethal hit stage of cytotoxicityJ C Hiserodt
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structureJ C Hiserodt
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1981
Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytesJ C Hiserodt, B Bonavida
The Year in Immunology|January 1, 1989
Natural killer cells and tumor immunityJ C Hiserodt, R B Herberman
Cellular Immunology|October 1, 1976
In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytesJ C Hiserodt, G A Granger
Medical Hypotheses|March 1, 1989
The importance of splenectomy for the adoptive immunotherapy of cancerR E Schwarz, J C Hiserodt
Cellular Immunology|April 15, 1992
Identification and partial characterization of a novel plasma membrane-associated lytic factor isolated from highly purified adherent lymphokine-activated killer cellsR E Felgar, J C Hiserodt
Journal of the Reticuloendothelial Society|October 1, 1978
The human lymphotoxin systemJ C Hiserodt, G A Granger
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Cancer Investigation|January 1, 1993
Lymphokine-activated killer cells: biology and relevance to diseaseJ C Hiserodt
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|December 1, 1991
Some thoughts on the cytolytic mechanism of natural killer lymphocytesJ C Hiserodt
Advances in Experimental Medicine and Biology|January 1, 1985
A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the lethal hit stage of cytotoxicityJ C Hiserodt
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structureJ C Hiserodt
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1981
Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytesJ C Hiserodt, B Bonavida
The Year in Immunology|January 1, 1989
Natural killer cells and tumor immunityJ C Hiserodt, R B Herberman
Cellular Immunology|October 1, 1976
In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytesJ C Hiserodt, G A Granger
Medical Hypotheses|March 1, 1989
The importance of splenectomy for the adoptive immunotherapy of cancerR E Schwarz, J C Hiserodt
Cellular Immunology|April 15, 1992
Identification and partial characterization of a novel plasma membrane-associated lytic factor isolated from highly purified adherent lymphokine-activated killer cellsR E Felgar, J C Hiserodt
Journal of the Reticuloendothelial Society|October 1, 1978
The human lymphotoxin systemJ C Hiserodt, G A Granger
Pageof 10